Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garrick Paul Smith

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers in Cellular Neuroscience|July 23, 2016
Protection of Primary Dopaminergic Midbrain Neurons by GPR139 Agonists Supports Different Mechanisms of MPP(+) and Rotenone ToxicityKirsten Bayer Andersen, Jens Leander Johansen, Morten Hentzer, et al.
Acta Pharmacologica Sinica|June 2, 2015
High-throughput screening of antagonists for the orphan G-protein coupled receptor GPR139Jia Wang, Lin-yun Zhu, Qing Liu, et al.
Eneuro|November 6, 2019
Long-Term Exposure to PFE-360 in the AAV-α-Synuclein Rat Model: Findings and ImplicationsMichael Aagaard Andersen, Florence Sotty, Poul Henning Jensen, et al.
Human Molecular Genetics|April 11, 2014
Abnormal visual gain control in a Parkinson's disease modelFarinaz Afsari, Kenneth V Christensen, Garrick Paul Smith, et al.
Neurobiology of Disease|April 23, 2018
Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-α-synuclein is normalized by LRRK2 modulationMichael Aagaard Andersen, Kenneth Vielsted Christensen, Lassina Badolo, et al.
Toxicology|January 9, 2018
PFE-360-induced LRRK2 inhibition induces reversible, non-adverse renal changes in ratsMichael Aagaard Andersen, Karen Malene Wegener, Steen Larsen, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Development of <sup>18</sup>F/<sup>11</sup>C-Labeled Pyrrolo-Pyridine/Pyrimidine LRRK2 Selective PET RadioligandsSangram Nag, Vladimir Stepanov, Akihiro Takano, et al.
Cerebral Cortex (New York, N.Y. : 1991)|January 23, 2016
Asc-1 Transporter Regulation of Synaptic Activity via the Tonic Release of d-Serine in the ForebrainHagit Sason, Jean Marie Billard, Garrick Paul Smith, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Cellular Neuroscience|July 23, 2016
Protection of Primary Dopaminergic Midbrain Neurons by GPR139 Agonists Supports Different Mechanisms of MPP(+) and Rotenone ToxicityKirsten Bayer Andersen, Jens Leander Johansen, Morten Hentzer, et al.
Acta Pharmacologica Sinica|June 2, 2015
High-throughput screening of antagonists for the orphan G-protein coupled receptor GPR139Jia Wang, Lin-yun Zhu, Qing Liu, et al.
Eneuro|November 6, 2019
Long-Term Exposure to PFE-360 in the AAV-α-Synuclein Rat Model: Findings and ImplicationsMichael Aagaard Andersen, Florence Sotty, Poul Henning Jensen, et al.
Human Molecular Genetics|April 11, 2014
Abnormal visual gain control in a Parkinson's disease modelFarinaz Afsari, Kenneth V Christensen, Garrick Paul Smith, et al.
Neurobiology of Disease|April 23, 2018
Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-α-synuclein is normalized by LRRK2 modulationMichael Aagaard Andersen, Kenneth Vielsted Christensen, Lassina Badolo, et al.
Toxicology|January 9, 2018
PFE-360-induced LRRK2 inhibition induces reversible, non-adverse renal changes in ratsMichael Aagaard Andersen, Karen Malene Wegener, Steen Larsen, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Development of <sup>18</sup>F/<sup>11</sup>C-Labeled Pyrrolo-Pyridine/Pyrimidine LRRK2 Selective PET RadioligandsSangram Nag, Vladimir Stepanov, Akihiro Takano, et al.
Cerebral Cortex (New York, N.Y. : 1991)|January 23, 2016
Asc-1 Transporter Regulation of Synaptic Activity via the Tonic Release of d-Serine in the ForebrainHagit Sason, Jean Marie Billard, Garrick Paul Smith, et al.
Pageof 1